APA Citatie

Dudek, A. Z., Pang, H., Kratzke, R. A., Otterson, G. A., Hodgson, L., Vokes, E. E., & Kindler, H. L. (2012). Phase II study of dasatinib in patients with previously treated malignant mesothelioma (Cancer and Leukemia Group B 30601): A brief report.

Chicago Style citaat

Dudek, Arkadiusz Z., Herbert Pang, Robert A. Kratzke, Gregory A. Otterson, Lydia Hodgson, Everett E. Vokes, en Hedy L. Kindler. Phase II Study of Dasatinib in Patients With Previously Treated Malignant Mesothelioma (Cancer and Leukemia Group B 30601): A Brief Report. 2012.

MLA citatie

Dudek, Arkadiusz Z., et al. Phase II Study of Dasatinib in Patients With Previously Treated Malignant Mesothelioma (Cancer and Leukemia Group B 30601): A Brief Report. 2012.